Supply Chain Transparency and Responsible Sourcing
Statement on Counterfeit Health Care Products
Statement on Counterfeit Health Care Products

At Johnson & Johnson we believe our first responsibility is to the doctors, nurses and patients, mothers and fathers and all others who use our products. In today’s global economy, where patients and consumers may be exposed to counterfeit products of all kinds, we must take tangible steps to help ensure they receive the genuine products of the Johnson & Johnson Family of Companies.

Counterfeiting of health care products is a serious and growing concern because it causes fake, untested, unapproved and potentially dangerous products to enter the marketplace. Moreover, it can undermine confidence in product safety and effectiveness while putting people’s health and lives at risk. According to the World Health Organization, counterfeiting is a global issue, difficult to quantify and gaining momentum.

Johnson & Johnson operating companies take a variety of approaches to identify and mitigate the risks of counterfeit health care products. They include a range of product and packaging security measures that help distinguish the authentic product from a counterfeit, and aid in minimizing the potential for tampering. We are continually working to make improvements in the supply chain — from sourcing of ingredients and manufacturing through distribution — to help minimize the risk of counterfeit products entering the system.

We monitor markets and investigate counterfeiting activities. We collaborate with regulatory and law enforcement authorities, as well as our business partners, to locate and remove counterfeits from the market, seize and destroy the manufacturing equipment, and prosecute or take civil action against the perpetrators.

We work with governments and regulators to identify opportunities to strengthen laws and enforcement efforts in order to ensure the integrity of distribution channels. Additionally, we are working to raise awareness of the dangers of counterfeit health care products and to educate stakeholders on the role they can play in helping to eliminate this illicit trade.

Download PDF

Last Updated: September 2016

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.